# Whole-Genome Sequence Analysis and Subtractive Screening of Lactobacilli in the Searching for New Probiotics to Protect the Mammary Glands

**Authors:** Dobroslava Bujňáková, Tímea Galambošiová, Lívia Karahutová

PMC · DOI: 10.3390/ijms262110809 · International Journal of Molecular Sciences · 2025-11-06

## TL;DR

This study identifies a safe Lactobacillus strain that could act as a probiotic to protect mammary glands from infections.

## Contribution

A novel Lactobacillus salivarius isolate with probiotic potential and no harmful genes was identified.

## Key findings

- Ligilactobacillus salivarius 48 showed strong antimicrobial activity against pathogens.
- The isolate exhibited moderate-to-high biofilm formation.
- No antibiotic-resistance or virulence genes were found in its genome.

## Abstract

To discover new probiotics that can protect mammary glands from mastitis, 40 Lactobacillus (Ligilactobacillus) spp. isolates from bovine milk were subjected to a preliminary series of in vitro subtractive analyses. Antibiotic susceptibility testing was performed according to the ISO norm 10932. Many lactobacilli had elevated MIC values for kanamycin (35%), but fewer were resistant to chloramphenicol (15%), streptomycin (7.5%) and tetracycline (5%). The enzymic activities of lactobacilli were tested using an API ZYM system. Nearly 27% exhibited undesirable activities (β-glucuronidase, β-glucosidase and N-acetyl-β-glucosaminidase). The safe strains were monitored for antimicrobial activity against Staphylococcus aureus, Escherichia coli, Salmonella enteritidis, and Bacillus cereus using microtiter plates and for their ability to form biofilms using the crystal violet assay. The antimicrobial activity of lactobacilli against indicator bacteria ranged from 29 to 89% and the isolates exhibited moderate-to-high biofilm formation. Suitable strains were selected for whole-genome sequencing analysis. Antibiotic-resistance genes and putative virulence genes were not predicted in the genomic analysis. Moreover, the isolate Ligilactobacillus salivarius 48 carries genetic information responsible for bacteriocin production that is similar to that encoding salivaricin CRL1328. Our study demonstrates the safety of the above mentioned isolate, which has potential to be used as a probiotic, exerting health benefits through production of antimicrobial substances.

## Linked entities

- **Chemicals:** kanamycin (PubChem CID 6032), chloramphenicol (PubChem CID 5959), streptomycin (PubChem CID 5297), tetracycline (PubChem CID 54675776)
- **Diseases:** mastitis (MONDO:0006849)
- **Species:** Lactobacillus (taxon 1578), Ligilactobacillus salivarius (taxon 1624), Staphylococcus aureus (taxon 1280), Escherichia coli (taxon 562), Bacillus cereus (taxon 1396)

## Full-text entities

- **Genes:** HEXB (hexosaminidase subunit beta) [NCBI Gene 618571], GUSB (glucuronidase beta) [NCBI Gene 515687]
- **Diseases:** mastitis (MESH:D008413)
- **Chemicals:** crystal violet (MESH:D005840), streptomycin (MESH:D013307), chloramphenicol (MESH:D002701), tetracycline (MESH:D013752), kanamycin (MESH:D007612)
- **Species:** Salmonella enterica subsp. enterica serovar Enteritidis (no rank) [taxon 149539], Staphylococcus aureus (species) [taxon 1280], Escherichia coli (E. coli, species) [taxon 562], Lactobacillus (genus) [taxon 1578], Bos taurus (bovine, species) [taxon 9913], Bacillus cereus (species) [taxon 1396]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12608424/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12608424/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12608424/full.md

---
Source: https://tomesphere.com/paper/PMC12608424